Clinical Trial Update: The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of SP2086 administered as single and multiple doses in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: UNKNOWN